Set as home page    Add to collection
 
 
 
 
 
 
 
 
 
 
    News Home  >  News  
 
The successful participation in CPhI China brings Holypharm new development opportunities.
Date:2013-07-04
 

Thougha wide exposure to foreign and domestic customers, Holypharm gets plenty of newbusiness chances in CPhI China 2013. Particularly, through a face to facecommunication, we made breakthrough of business relationships with some veryimportant customers for our key projects, including Moxidectin, Brinzolamide,Ulipristal Acetate, Atorvastatin Calcium Amorphous and Caspofungin Acetate.

Besidesthe API business, potential partners for generic finished product visited ourbooth for our import and distribution business.

Thanksto the great kindness of our partners and the joint efforts of all ourcolleagues, Holypharm did a good job in Shanghai. We hope to see you again atthe CPhI Worldwide in Frankfurt!


 
 
 
 
ABOUT US
Profile
Responsibility
News
 
PRODUCTS
Veterinary
Antibiotics
Antivirus
Antineoplastics
Cardiovascular
Nervous System
Cosmetic Ingredients
Gastrointestinal
Peptide
Others
SERVICES
CRAM
Representative Business
Regulatory Affairs
CONTACT US
Contact Us
Message Board
TTCopyright © 2011 Allrights Reserved. Patented products available for research only.E-mail: info@holypharm.com